Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

BBH VanEck Vectors Biotech ETF

  • Fund Description

    VanEck Vectors Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

  •  
      

    • Fund Ticker

      BBH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVBBHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 09/28/16

    • 30-Day SEC Yield1

      0.28%
    • Total Net Assets

      $607.4M
    • Number of Holdings

      25
    • Options

      Available
    • Gross Expense Ratio2

      0.40%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Annual
    • Next Distribution Date

      12/16/2016
  • Portfolio Composition (%)
    as of 09/28/16

    • % of Net Assets
    • Stocks

      95.52
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      4.48
  • Daily HoldingsDaily Holdings (%) as of 09/28/16

    Total Holdings: 25
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Amgen Inc
    AMGN US
    446,730
    75,814,54812.48
    Gilead Sciences Inc
    GILD US
    861,288
    68,015,91311.20
    Allergan Plc
    AGN US
    245,816
    58,452,5879.62
    Celgene Corp
    CELG US
    536,733
    56,802,4539.35
    Biogen Inc
    BIIB US
    127,315
    39,537,6736.51
    Illumina Inc
    ILMN US
    158,884
    28,754,8264.73
    Regeneron Pharmaceuticals Inc
    REGN US
    67,377
    28,237,7014.65
    Biomarin Pharmaceutical Inc
    BMRN US
    280,253
    26,912,6964.43
    Alexion Pharmaceuticals Inc
    ALXN US
    215,393
    26,657,0384.39
    Vertex Pharmaceuticals Inc
    VRTX US
    281,836
    25,038,3104.12
    Incyte Corp
    INCY US
    259,076
    24,145,8833.98
    Quintiles Transnational Holdings Inc
    Q US
    238,610
    18,986,1983.13
    Qiagen Nv
    QGEN US
    510,828
    13,945,6042.30
    Grifols Sa
    GRFS US
    671,384
    10,762,2861.77
    Charles River Laboratories Internationa
    CRL US
    124,420
    10,395,2911.71
    United Therapeutics Corp
    UTHR US
    85,767
    10,177,9701.68
    Alnylam Pharmaceuticals Inc
    ALNY US
    128,871
    9,880,5401.63
    Alkermes Plc
    ALKS US
    185,118
    9,035,6101.49
    Seattle Genetics Inc
    SGEN US
    154,030
    8,522,4801.40
    Neurocrine Biosciences Inc
    NBIX US
    160,302
    8,242,7291.36
    Tesaro Inc
    TSRO US
    75,610
    7,895,1961.30
    Ionis Pharmaceuticals Inc
    IONS US
    189,354
    6,854,6151.13
    Intercept Pharmaceuticals Inc
    ICPT US
    24,781
    4,155,2780.68
    Bluebird Bio Inc
    BLUE US
    43,073
    2,976,7750.49
    Other/Cash
    --
    --
    27,234,7754.48
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.